Company Centrexion Therapeutics Corporation
Equities
CNTX
US15643W1009
Biotechnology & Medical Research
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 76 | 13-01-31 | |
Jeffrey Kindler
FOU | Founder | 68 | 13-01-31 |
Chief Tech/Sci/R&D Officer | - | 15-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Swedish
BRD | Director/Board Member | 72 | 18-06-25 |
Sol Barer
FOU | Founder | 76 | 13-01-31 |
Jeffrey Kindler
FOU | Founder | 68 | 13-01-31 |
Peter Wirth
BRD | Director/Board Member | 73 | - |
Director/Board Member | 83 | 13-01-31 | |
Daniel Mendelson
BRD | Director/Board Member | 60 | 18-08-14 |
Founder | 76 | 13-01-31 | |
Sara Nayeem
BRD | Director/Board Member | 75 | 17-12-31 |
Shawn Tomasello
BRD | Director/Board Member | 65 | 17-06-25 |
Stella Xu
BRD | Director/Board Member | 53 | 17-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,669,866 | 0 | 0 | - |
Company contact information
Centrexion Therapeutics Corp.
200 State Street 6th floor
02109, Boston
+617-837-6911
http://www.centrexion.comSector
1st Jan change | Capi. | |
---|---|---|
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |